Angiotensin-converting enzyme inhibition reverses luteal phase steroid production in oocyte donors
|
|
- Kristopher Taylor
- 6 years ago
- Views:
Transcription
1 FERTILITY AND STERILITY Copyright c 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Angiotensin-converting enzyme inhibition reverses luteal phase steroid production in oocyte donors Randy S. Morris, M.D. Richard J. Paulson, M.D. Steven R. Lindheim, M.D. Richard S. Legro, M.D. Rogerio A. Lobo, M.D. Mark V. Sauer, M.D.t Division of Reproductive Endocrinology and In Vitro Fertilization Program at California Medical Center, University of Southern California, Los Angeles, California Objective: To determine whether angiotensin-converting enzyme (ACE) inhibition would affect ovarian steroid synthesis in the oocyte donors undergoing controlled ovarian hyperstimulation (COH). Setting: The IVF program of the University of Southern California. Design: Prospective matched clinical trial. Patients: Twelve oocyte donors were studied in 28 hyperstimulation cycles. Interventions: Donors underwent a standard COH protocol. Follicle aspiration was performed 34 hours after administration of hcg. After the procedure, seven donors were administered the ACE inhibitor, captopril, 6.25 mg orally twice daily for 4 days. The remaining patients served as controls. Main Outcome Measures: Serum E2, P, plasma prorenin, active renin, and angiotensin II (Ang 11). Results: Angiotensin II increased after aspiration in both groups but was significantly lower in those receiving captopril. Peak P in the captopril group was significantly lower than controls (81.8 ± 27.8 versus ± 23.9 ng/ml [conversion factor to SI unit, 3.180]). Peak E2 was significantly higher (2,222.4 ± versus ± [conversion factor to SI unit, 3.671]). Active renin and Ang II correlated with P. Conclusions: In stimulated cycles, inhibition of Ang II production appears to raise serum E2 and lower P levels. Angiotensin II, therefore, may have a role in the regulation of ovarian steroid synthesis. Fertil Steril 1995;63:854-8 Key Words: Ovarian-derived prorenin to angiotensin cascade (ODPAC), angiotensin-converting enzyme (ACE) inhibition, captopril, oocyte donation, ovarian steroid synthesis, ovarian hyperstimulation syndrome (OHSS) Aberrations in the ovarian-derived pro renin to angiotensin cascade have been implicated in the Received May 23, 1994; revised and accepted October 26, * Presented at the Conjoint Meeting of The American Fertility Society and the Canadian Fertility and Andrology Society, October 11 to 14, 1993, Montreal, Quebec, Canada. t Reprint requests: Mark V. Sauer, M.D., University of Southern California School of Medicine, Los Angeles County Women's and Children's Hospital, Division of Reproductive Endocrinology, 1240 North Mission Road, Room L-1013, Los Angeles, California (FAX: ). 854 Morris et al. ACE inhibition in oocyte donors pathophysiology of ovarian hyperstimulation syndrome (OHSS) (1). Angiotensin II (Ang II) has been demonstrated to increase vascular permeability, the underlying derangement in the development of OHSS (2). It has been suggested that inhibition of Ang II may be useful in the prevention or treatment of OHSS (3). However, Ang II has also been found to alter other aspects of ovarian physiology such as oocyte maturation and ovulation (4), corpus luteum angiogenesis (5), and steroid production (1). Before inhibition of Ang II can be advocated as a potential treatment, these other possible ovarian effects must be explored more fully.
2 We sought to determine whether use ofthe angiotensin-converting enzyme (ACE) inhibitor, captopril, would have any effect on ovarian steroid synthesis in a group of hyperstimulated patients. We chose to study oocyte donors because they have a very low risk of severe OHSS (Morris RS, Wong IL, Sauer MV, Lobo RA, Paulson RJ, abstract), receive no luteal phase hormone supplementation, and are not transferred embryos. Patients MATERIALS AND METHODS This protocol was approved in advance by the Institutional Review Board of the University of Southern California School of Medicine. Volunteers were recruited from the oocyte donor program at the University of Southern California. Each patient previously had been through at least one donation cycle and was therefore known to have a satisfactory response to gonadotropin stimulation. All donors were between 18 and 35 years of age (mean ± SEM, 25 ± 4 years). Donors were free of any serious medical problems and were not taking any medications during the study cycle except those required for controlled ovarian hyperstimulation (COH). All patients previously had passed routine screening procedures for donation as described previously (6). Stimulation Protocol Down regulation was achieved either in the luteal phase with 1 mgjd leuprolide acetate (LA) for 14 days or in the follicular phase with LA for 14 days and 5 mgjd norethindrone for 5 days (Paulson RJ, Sauer MV, Francis MM, Macaso TM, Lobo RA, abstract) Follicular-phase down regulation was used to assist in coordination with recipient cycles. One patient in each group underwent follicularphase down regulation. Down regulation was considered successful when serum E2 was <30 pgjml (conversion factor to SI unit, 3.671) in the absence of any ovarian cyst> 1.5 cm on transvaginal ultrasound. Controlled ovarian hyperstimulation was then initiated with either FSH (Metrodin; Serono, Norwell, MA) or hmg (Pergonal; Serono). Daily dosage was determined based on previous response and in most cases was between 150 and 225 IU. Cycle monitoring included serum E2 determinations and transvaginal ultrasound. Human chorionic gonadotropin (10,000 IU) was administered after appro- priate follicular development. The day of hcg administration is designated as day o. Follicles were aspirated 34 hours later. ACE Inhibition Seven patients were chosen randomly to receive the ACE inhibitor, captopril (Capoten; Squibb, Princeton, NJ), 6.25 mg orally twice daily starting on the day of aspiration. This low dose was chosen to avoid any possibility of precipitous blood pressure decrements. Treatment was continued for 4 days. An additional five patients were studied who received no medications during this time. Compliance was monitored by pill counting and frequent telephone contact. Collections Blood samples were obtained on the day of hcg administration, the day of aspiration, and again 2 and 4 days later. Venipuncture was performed on the antecubital vein with the patient in a sitting position for ~10 minutes. All blood was collected between 8:00 and 10:00 A.M. Samples for plasma prorenin and active renin were collected into ethylenediaminetetraacetic acid (EDT A) containing tubes at room temperature. Within 30 minutes samples were centrifuged at room temperature at 3,000 X g for 15 minutes duration. Plasma was pipetted into 2-mL cryotubes and immediately plunged and stored in liquid nitrogen until assay. Samples for Ang II were collected into prechilled EDT A containing tubes. Samples were kept on ice until centrifugation in. a refrigerated centrifuge (4 C). Plasma was pipetted into 2-mL cryotubes and immediately plunged and stored in liquid nitrogen until assay. The remaining samples were prepared in the same manner as the plasma prorenin. Assays Plasma active renin levels were determined directly using a commercially available immunoradiometric assay (Nichols Institute Diagnostics, San Juan Capistrano, CA). Plasma prorenin was determined after complete activation of the plasma prorenin in the specimen and then finding the difference (plasmaprorenin = total renin - active renin). The interassay and intra -assay coefficients of variation are 9.9% and 2.5%. Angiotensin II was measured using an extraction RIA kit (Nichols Institute Diagnostics). The interassay and intra-assay coefficients of variation are 9.3% and 4.0%. Estra- Morris et al. ACE inhibition in oocyte donors 855
3 ANGII 100r ~ CONTROL -CAPTOPRIL n-----" " L ~6 DAY Figure 1 Angiotensin II levels in the luteal phase. Day 0 = day of hcg administration (*P < 0.05) (conversion factor to SI unit, ). diol and P were measured by standard RIA methods. The interassay and intra-assay coefficients of variation did not exceed 10% and 5% in any assay. Statistics All data are presented as the mean ± SEM. Changes from baseline within each group were determined using analysis of variance (ANOVA) with the Bonferroni correction for multiple time points. Differences between groups were determined by single-measure ANOVA. Linear regression analysis was used when correlating continuous variables. RESULTS Figure 1 shows the Ang II levels in both groups. Baseline Ang II levels were similar. Although Ang II increased in both groups, levels were significantly lower in those who received captopril (P < 0.05). Levels of plasma prorenin, active renin, and Ang II on day 0 were elevated compared with the luteal phase of unstimulated cycles (Morris RS, Paulson RJ, Lindheim SR, Legro RS, Lobo RA, Sauer MV, unpublished observations). Levels of plasma prorenin and active renin can be seen in Table 1. Estradiol levels were not different between the two groups on either the day of hcg (day 0) or the day of aspiration (day 2). By day 6, however, E2 in the captopril group was significantly higher than controls (P = 0.004, Fig. 2A). By contrast, P levels, although initially similar (8.14 ± 1.1 versus 8.2 ± 1.2 ngjml; conversion factor to SI unit, 3.180; not significant), increased at a slower rate in the captopril group so that by day 6 levels in the captopril group were significantly lower compared with 856 Morris et al. ACE inhibition in oocyte donors Table 1 Levels of Plasma Prorenin and Active Renin After Aspiration* Plasma prorenint:j: Active renint:j: Day Control Captopril Control Captopril ± ± ± 6 32 ± ± ± ± 6 32 ± ± ± ± 6 43 ± 7 * Values are means ± SEM. t Conversion factor to SI units, :j: No significant differences between control and captopril groups by unpaired t-test. the untreated controls (P < 0.05, Fig. 2B). A significant correlation was found to exist between active renin and P (r = 0.473, P = 0.017) and Ang II and P (r = 0.734, P < 0.001). DISCUSSION DAY I-CAPTOPAIL The importance of ovarian-derived prorenin to angiotensin cascade is uncertain but it has been suggested that it plays a role in steroid modulation. Angiotensin II produced from the kidney renin-angiotensin system has as one of its principle functions the stimulation of aldosterone secretion from the adrenal cortex (7). This is accomplished via Ang II interaction with the cytochrome P-450 sidechain cleavage (Cyt-P450scc) enzyme, which converts cholesterol into pregnenolone (8). Because this enzyme serves as the rate-limiting step in step ng/ml B CONTROL Figure 2 (A), Estradiol levels in the lutealphase (* P = 0.004). (B), Progesterone levels in the luteal phase (*P < 0.05) 0 = day of hcg administration; 2 = day of aspiration (conversion factor to SI units, P, 3.180; E 2, 3.671).
4 roid synthesis in the adrenal cortex and the ovary, it is feasible that Ang II has a similar function in both. In nonhuman mammals, a number of investigators have shown alterations in steroid synthesis in response to Ang II. Pucell et al. (9) demonstrated an increase in P in cultured rat granulosa cells but the effect was not concentration dependent. On the other hand, Aguilera et al. (10) found decreased P and increased E2 production when Ang II was administered concomitantly with gonadotropins in the rat. When captopril was added, the effect was reversed. The bovine corpus luteum responded by decreasing P secretion with Ang II and increasing it with saralasin (11). Morris and Paulson (1) reported on the effects of Ang II on E2 and P production by luteinized human granulosa cells in culture. In the presence of hcg, Ang II caused a dose-dependent increase in the amount of P produced. This effect was blocked by the addition of saralasin to the cultures. Angiotensin II seemed to have no effect on E2 production. However, when saralasin was added, a substantial increase in E2 was seen, suggesting that Ang II may serve to tonically inhibit E2 secretion. Although this effect was felt to be caused most likely by an inhibition of aromatase, no consistent effect was seen on T levels. Palumbo et al. (12), using a similar model, showed increased levels of all three steroids (E2, P, and T). By contrast, Rainey et al. (13) found that Ang II, either alone or in combination with FSH or LH, did not alter the release of P from fresh or cultured granulosa cells. The results of the present in vivo experiment are parallel to the in vitro results of Morris and Paulson (1). That is, Ang II inhibition resulted in an increase in E2 and a decrease in P levels. It is possible that Ang II has a stimulatory effect on Cyt P450scc just as in the adrenal but in addition has an inhibitory effect on aromatase. Severe OHSS has been associated with elevations in various components of ovarian -derived prorenin to angiotensin cascade. Navot et al. (14) showed that patients with severe OHSS demonstrated enhanced renin activity compared with controls. Ong et al. (15) noted elevations in plasma prorenin, active renin, and aldosterone. In gonadotropin-stimulated cycles, plasma prorenin increases markedly 8 to 16 hours after administration of hcg and peaks in 4 to 6 days (16). Higher levels of renin activity are detectable by 8 days after hcg in those patients who subsequently develop severe OHSS as opposed to those with mild hyperstimulation or controls (15). If ovarian-derived pro renin to angiotensin cascade is involved in the pathogenesis of OHSS, inhibition before this time would seem preferable. The present study examined this time period and reveals that significant changes in the hormonal milieu may be expected if ACE inhibitors are used to attempt prevention of OHSS. Angiotensin-converting enzyme inhibitors have been used successfully to treat other syndromes of increased vascular permeability such as retinopathy and nephropathy (17, 18). However, in the present study none of the patients in either the captopril or the control group developed severe OHSS. Therefore, this study cannot adequately test the efficacy of captopril as a treatment for established OHSS. In conclusion, ACE inhibition is capable of altering ovarian steroid synthesis in the luteal phase of hyperstimulated cycles. Specifically, E2 levels are higher and P levels are lower than in comparable controls. This effect may be of importance if ACE inhibitors are used in the luteal phase of stimulation cycles for IVF or ovulation induction for the treatment or prevention of OHSS. Acknowledgments. Special thanks to Rachel A. McConnell, M.D. (University of Southern California, Division of Reproductive Endocrinology, Los Angeles, CAl for her assistance in data collection. REFERENCES 1. Morris RS, Paulson RJ. Ovarian derived prorenin to angiotensin cascade in human reproduction. Fertil Steril 1994;62: Robertson AL, Khairallah P A. Effects of angiotensin II and some analogues on vascular permeability in the rabbit. Circ Res 1972;31: Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992;58: Pellicer A, Palumbo A, DeCherney AH, Naftolin F. Blockage of ovulation by an angiotensin antagonist. Science 1988;240: Fernandez CA, Twickler J, Mead A. Neovascularization produced by angiotensin II. J Lab Clin Med 1985;105: Sauer MV, Paulson RJ, Macaso TM, Francis-Hernandez M, Lobo RA. Establishment of a nonanonymous donor oocyte program: preliminary experience at the University of Southern California. Fertil Steril 1989;52:433; Peach MJ. Renin-angiotensin system: biochemistry and mechanism of action. Physiol Rev 1977;57: Kramer RE, Gallant S, Brownie AC. Actions of angiotensin Morris et al. ACE inhibition in oocyte donors 857
5 II on aldosterone biosynthesis in the rat adrenal cortex. J Bioi Chern 1980;255: Pucell AG, Bumpus FM, Husain A. Rat ovarian angiotensin II receptors: characterization and coupling to estrogen secretion. J Bioi Chern 1987;262: Aguilera G, Millan MA, Harwood JP. Angiotensin II receptors in the gonads. Am J Hypertens 1989;2: Stirling D, Magness RR, Stone R, Waterman MR, Simpson ER. Angiotensin II inhibits luteinizing hormone stimulated cholesterol side chain cleavage expression and stimulates basic fibroblast growth factor expression in bovine luteal cells in primary culture. J Bioi Chern 1990;265: Pepperell JR, Nemeth G, Palumbo A, Naftolin F. The Intraovarian renin-angiotensin system. In: Adashi EY, Leung PCK, editors. The ovary. New York: Raven Press, 1993: Rainey WE, Bird 1M, Byrd W, Carr BR. Effect of angiotensin II on human luteinized granulosa cells. Fertil Steril 1993;59: Navot D, Margoliath EJ, Laufer N, Birkenfeld A, Relou A, Rosier A, et al. Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil SteriI1987;48: Ong ACM, Eisen V, Rennie DP, Homburg R, Lachelin GCL, Jacobs HS, et al. The pathogenesis of the ovarian hyperstimulation syndrome: a possible role for ovarian renin. Clin Endocrinol (OxO 1991;34: Sealey JE, Glorioso N, ltskovitz J, TroffC, Cholst I, Rosenwaks Z. Plasma prorenin during early pregnancy: ovarian secretion under gonadotropin control? J Hypertens Suppl 1986;4(SuppI5):s92-s Larsen M, Hommel E, Parving HH, Lund-Anderson H. Protective effect of captopril on the blood retina barrier in normotensive insulin dependent diabetic patients with nephropathy and background retinopathy. Graefes Arch Clin Exp Ophthalmol 1990;228: Stornello M, Valvo EV, Puglia N, Scapellato L. Angiotensin converting enzyme inhibition with a low dose of enalapril in normotensive diabetics with persistent proteinuria. J Hypertens 1988;6(Suppl 4):s Morris et al. ACE inhibition in oocyte donors
Ovarian derived prorenin-angiotensin cascade in human reproduction
FERTILITY AND STERILITY Copyright c 1994 The American Fertility Society Vol. 62, No. 6, December 1994 Printed on acid-free paper in U. S. A. Ovarian derived prorenin-angiotensin cascade in human reproduction
More informationSuperovulation of Beef Heifers with Follicle Stimulating Hormone or Human Menopausal Gonadotropin: Acute Effects on Hormone Secretion
Superovulation of Beef Heifers with Follicle Stimulating Hormone or Human Menopausal Gonadotropin: Acute Effects on Hormone Secretion A.S. Leaflet R1362 Acacia A. Alcivar, graduate research assistant,
More informationSuperovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony*
aes FERTILITY AND STERILITY Vol. 61, No.4, April 1994 Copyright ee) 1994 The American Fertility Society Printed on acid-free paper in U. S. A. r I Superovulation with human menopausal gonadotropins is
More informationPrognostic value of day 3 estradiol on in vitro fertilization outcome*
FERTILITY AND STERILITY Vol. 64, No.6, December 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Prognostic value of day 3 estradiol on in vitro fertilization
More informationEndocrinology of the Female Reproductive Axis
Endocrinology of the Female Reproductive Axis girlontheriver.com Geralyn Lambert-Messerlian, PhD, FACB Professor Women and Infants Hospital Alpert Medical School at Brown University Women & Infants BROWN
More informationIVF Protocols: Hyper & Hypo-Responders, Implantation
IVF Protocols: Hyper & Hypo-Responders, Implantation Midwest Reproductive Symposium June 4-5, 4 2010 Subset : Hyper-Responders Mark R. Bush, MD, FACOG, FACS OBJECTIVE: Important goals for the PCOS patient
More informationMilan Reljič, Ph.D., Veljko Vlaisavljević, Ph.D., Vida Gavrić, M.Sc., Borut Kovačič, Ph.D.,
FERTILITY AND STERILITY VOL. 75, NO. 3, MARCH 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Value of the serum estradiol
More informationSuperovulation of Beef Heifers with Follicle Stimulating Hormone or Human Menopausal Gonadotropin: Acute Effects on Hormone Secretion
Beef Research Report, 1996 Animal Science Research Reports 1997 Superovulation of Beef Heifers with Follicle Stimulating Hormone or Human Menopausal Gonadotropin: Acute Effects on Hormone Secretion Acacia
More informationLuteal phase rescue after GnRHa triggering Progesterone and Estradiol
Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective
More informationThe Human Menstrual Cycle
The Human Menstrual Cycle Name: The female human s menstrual cycle is broken into two phases: the Follicular Phase and the Luteal Phase. These two phases are separated by an event called ovulation. (1)
More informationFertility Diagnostics
Fertility Diagnostics Fertility hormones measured on PATHFAST For internal use only Diagnostics PATHFAST Chemiluminescence-immuno-analyzer 1 Content: page 1. Fertility hormones - general aspects 1.1 Reproductive
More informationFemale Reproductive System. Lesson 10
Female Reproductive System Lesson 10 Learning Goals 1. What are the five hormones involved in the female reproductive system? 2. Understand the four phases of the menstrual cycle. Human Reproductive System
More information10.7 The Reproductive Hormones
10.7 The Reproductive Hormones December 10, 2013. Website survey?? QUESTION: Who is more complicated: men or women? The Female Reproductive System ovaries: produce gametes (eggs) produce estrogen (steroid
More informationComparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization
Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization Peter Kovacs, M.D., a Timea Kovats, M.D., a Artur Bernard,
More informationCASE 41. What is the pathophysiologic cause of her amenorrhea? Which cells in the ovary secrete estrogen?
CASE 41 A 19-year-old woman presents to her gynecologist with complaints of not having had a period for 6 months. She reports having normal periods since menarche at age 12. She denies sexual activity,
More informationHCG (human chorionic gonadotropin); Novarel Pregnyl (chorionic gonadotropin); Ovidrel (choriogonadotropin alfa)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.08.09 Subject: HCG Page: 1 of 5 Last Review Date: June 19, 2015 HCG Powder, Novarel, Pregnyl, Ovidrel
More informationPremature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles
Arch Gynecol Obstet (2010) 281:747 752 DOI 10.1007/s00404-009-1248-0 REPRODUCTIVE MEDICINE Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles Esra
More informationEffects of norethindrone on gonadotropin and ovarian steroid secretion when used for cycle programming during in vitro fertilization
FERTILITY AND STERILITY Copyright 1990 The American Fertility Society Printed on acid-free paper in U.S.A Effects of norethindrone on gonadotropin and ovarian steroid secretion when used for cycle programming
More informationLUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi
LUTEAL PHASE SUPPORT Doç. Dr. Nafiye Yılmaz Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi TAJEV, 2014 1 ART & success *Live birth rate 2 Optimal luteal phase Etiology of luteal phase deficiency
More informationDoes triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *
Middle East Fertility Society Journal Vol. 11, No. 2, 2006 Copyright Middle East Fertility Society Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Amany A.M. Shaltout, M.D. Mohamed
More informationPrinciples of Ovarian Stimulation
Principles of Ovarian Stimulation Dr Genia Rozen Gynaecologist and Fertility Specialist Royal Women s Hospital and Melbourne IVF Learning objectives Why ovarian stimulation Recap physiology Ovarian cycle
More informationAssisted reproductive technology
Assisted reproductive technology FERTILITY AND STERILITY Vol. 60, No.2, August 1993 Copyright 'c; 199:~ The American Fertility Society Printed on acid-free paper in U. S. A. Natural cycle in vitro fertilization-embryo
More informationLH activity administration during the
LH activity administration during the luteal-follicular transition Richard Fleming On behalf of the Luveris Pre-treatment group University of Glasgow Scotland Androgens have a Paracrine action in the Early
More informationCONTROLLED OVARIAN HYPERSTIMULATION AND OOCYTE RETRIEVAL : CLINICAL INPUTS. DR Priyanka Sinha MD OB-GYN MUMBAI, INDIA
CONTROLLED OVARIAN HYPERSTIMULATION AND OOCYTE RETRIEVAL : CLINICAL INPUTS DR Priyanka Sinha MD OB-GYN MUMBAI, INDIA LEARNING OBJECTIVE Introduction Ovarian stimulation protocols Comparison of different
More informationSupraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles
Human Reproduction Vol.17, No.1 pp. 83 87, 2002 Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles Joseph E.Peña, Peter L.Chang 1, Lai-King Chan, Khaled
More informationOvulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age*
FERTILITY AND STERILITY Vol. 58, No.4, October 1992 Copyright It! 1992 The American Fertility Society Printed on acid-free paper in U. S.A. Ovulation induction in women age 40 and older: the importance
More informationProgesterone and clinical outcomes
Synchronization of Slowly Developing Embryos Restores Implantation Success Richard T. Scott, Jr, MD, HCLD Clinical and Scientific Director, Reproductive Medicine Associates of New Jersey Professor and
More informationOriginal Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer
Int J Clin Exp Med 2015;8(7):11327-11331 www.ijcem.com /ISSN:1940-5901/IJCEM0008838 Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and
More informationThe effects of prior gravidity on the outcomes of ovum donor and own oocyte cycles
FERTILITY AND STERILITY Vol. 65, No.3, March 1996 Copyright t';, 1996 American Society for Reproductive Medicine Printed on acid-free paper in U. s. A. The effects of prior gravidity on the outcomes of
More informationBIOSYNTHESIS OF STEROID HORMONES
BIOSYNTHESIS OF STEROID HORMONES Sri Widia A Jusman Department of Biochemistry & Molecular Biology FMUI sw/steroidrepro/inter/08 1 STEROID HORMONES Progestins (21 C) Glucocorticoids (21 C) Mineralocorticoids
More informationI. ART PROCEDURES. A. In Vitro Fertilization (IVF)
DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment
More informationEgg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer
FERTILITY AND STERILITY Copyright tl 1989 The American Fertility Society Printed on acid-free paper in U. S.A. Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization
More informationIs it the seed or the soil? Arthur Leader, MD, FRCSC
The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events
More informationN. Shirazian, MD. Endocrinologist
N. Shirazian, MD Internist, Endocrinologist Inside the ovary Day 15-28: empty pyfollicle turns into corpus luteum (yellow body) Immature eggs Day 1-13: 13: egg developing inside the growing follicle Day
More informationTreatment 3 Days After Ovulation In Mares
Luteal Regression And Follicle Development Following Prostaglandin-F 2α Treatment 3 Days After Ovulation In Mares D.R. Bergfelt a, R.A. Pierson b, and O.J. Ginther a a University of Wisconsin, Madison,
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Human Ovarian Steroidogenesis and Gonadotrophin Stimulation Johan
More informationREPRODUCTION & GENETICS. Hormones
REPRODUCTION & GENETICS Hormones http://www.youtube.com/watch?v=np0wfu_mgzo Objectives 2 Define what hormones are; Compare and contrast the male and female hormones; Explain what each hormone in the mail
More informationAgonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M
Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic
More informationThe Comparison of Clinical Outcomes between GnRH Agonist Long Protocol and GnRH Antagonist Short Protocol in Oocyte Donation Cycles
: 30 1 2003 Kor J Fertil Steril, Vol 30, No 1, 2003, 3 The Comparison of Clinical Outcomes between GnRH Agonist Long Protocol and GnRH Antagonist Short Protocol in Oocyte Donation Cycles Jeong Ho Rhee,
More information(1.,, ) (2.,,, )
33 11 Vol.33 No.11 2013 11 Nov. 2013 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2013.11.0749 E-mail: randc_journal@163.com IVF-ET 1 2 1 1 1 1 1 (1. 510150) (2. 510150) : (COH) (premature
More informationOvarian hyperstimulation syndrome- an optimal solution for an unresolved enigma
Orvieto Journal of Ovarian Research 2013, 6:77 REVIEW Open Access Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma Raoul Orvieto 1,2 Abstract Ovarian hyperstimulation syndrome
More informationUtility of in vitro fertilization at diagnostic laparoscopy*
FERTILITY AND STERILITY Copyright" 1994 The American Fertility Society Printed on acid-free paper in U. S. A. Utility of in vitro fertilization at diagnostic laparoscopy* Paul R. Gindoff, M.D.t Jerry L.
More informationthat induce morphologic (4, 5) and biochemical (6) endometrial alterations relevant to uterine receptivity.
FERTILITY AND STERILITY VOL. 70, NO. 2, AUGUST 1998 Copyright 1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. 12 Increasing uterine
More informationReproductive Progesterone
Reproductive Progesterone Analyte Information 1 Progesterone Introduction Progesterone is a natural gestagen belonging to the C 21 steroid group. It is also known as P4 (or pregn-4-ene-3,20-dione, or 4-pregnene-3,20-dione).
More informationClinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients
International Reproductive Medicine Volume 2013, Article ID 135258, 4 pages http://dx.doi.org/10.1155/2013/135258 Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin
More informationReproductive Hormones
Reproductive Hormones Male gonads: testes produce male sex cells! sperm Female gonads: ovaries produce female sex cells! ovum The union of male and female sex cells during fertilization produces a zygote
More informationTimur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D.
FERTILITY AND STEFULI~ Vol. 68, No. 3, September 1997 Copyright 1997 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Published by Elsevier Science Inc. Follicle-stimulating
More informationThe serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
Original Article Obstet Gynecol Sci 2018;61(2):242-246 https://doi.org/10.5468/ogs.2018.61.2.242 pissn 2287-8572 eissn 2287-8580 The serum estradiol/oocyte ratio in patients with breast cancer undergoing
More informationPatient Information: Patient Name: Date of Birth:
Weill Cornell Medicine Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine Informed Consent for Oocyte (Egg) Cryopreservation Patient Information: Part 1: I have requested to be treated
More informationin vitro fertilization
FERTILITY AND STERILITY VOL 69, NO. 6, JUNE 1998 Copyright (#1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Elevated levels of basal
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More informationlbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour
lbt lab tests t and Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour Research Instituteof Avicenna 4/23/2012 Why good prediction of poor response good prediction i of OHSS application appropriate
More informationCigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test*
FERTILITY AND STERILITY Copyright @ 1994 The American Fertility Society Printed on acid-free paper in U. s. A. Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by
More informationREPRODUCTIVE CYCLE OF FEMALE MAMMAL
REPRODUCTIVE CYCLE OF FEMALE MAMMAL Fig. 8-12 Secondary follicles growing follicles increase in number of layers of granulosa cells Tertiary follicles maturing follicles antrum formation fluid filled space
More informationIVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)
34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh
More informationReproductive System. Testes. Accessory reproductive organs. gametogenesis hormones. Reproductive tract & Glands
Reproductive System Testes gametogenesis hormones Accessory reproductive organs Reproductive tract & Glands transport gametes provide nourishment for gametes Hormonal regulation in men Hypothalamus - puberty
More informationIn Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome
Original Article Effect of Laparoscopic Ovarian Drilling on Outcomes of In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome Maryam Eftekhar, M.D. 1, Razieh Deghani Firoozabadi,
More informationDr. Ernesto Bosch Instituto Valenciano de Infertilidad Valencia, Spain. Declared no potential conflict of interest
Dr. Ernesto Bosch Instituto Valenciano de Infertilidad Valencia, Spain Declared no potential conflict of interest Is there a role for LH in elderly patients? Dr. Ernesto Bosch Instituto Valenciano de Infertilidad.
More informationOvarian Characteristics, Serum Hormone Concentrations, and Fertility in Lactating Dairy Cows in Response to Equine Chorionic Gonadotropin
Ovarian Characteristics, Serum Hormone Concentrations, and Fertility in Lactating Dairy Cows in Response to quine Chorionic Gonadotropin S. L. Pulley, L. D. Wallace, H. I. Mellieon, and J. S. Stevenson
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,
More informationThe effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study
Clinical research The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Ashraf Moini 1,2, Shahrzad Zadeh Modarress 3, Elham Amirchaghmaghi
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Infertility Injectables Table of Contents Coverage Policy... 1 General Background...16 Coding/Billing Information...20 References...20 Effective Date...
More informationBiology of Reproduction- Zool 346 Exam 2
Biology of Reproduction- Zool 346 Exam 2 ANSWER ALL THE QUESTIONS ON THE ANSWER SHEET. THE ANSWER ON THE ANSWER SHEET IS YOUR OFFICIAL ANSWER. Some critical words are boldfaced. This exam is 7 pages long.
More informationSredišnja medicinska knjižnica
Središnja medicinska knjižnica Kasum M., Kurdija K., Orešković S., Čehić E., Pavičić-Baldani D., Škrgatić L. (2016) Combined ovulation triggering with GnRH agonist and hcg in IVF patients. Gynecological
More informationREstradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization
REstradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? FTThe Journal of Reproductive
More informationReproductive physiology
Reproductive physiology Sex hormones: Androgens Estrogens Gestagens Learning objectives 86 (also 90) Sex Genetic sex Gonadal sex Phenotypic sex XY - XX chromosomes testes - ovaries external features Tha
More informationHerjan Coelingh Bennink, M.D.:j: Andre Van Steirteghem, M.D., Ph.D.* Paul Devroey, M.D., Ph.D.*
J FERTILITY AND STERILITY@ Copyright 't; 1996 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing
More informationConception rate after in vitro fertilization in patients who conceived in a previous cycle
FERTILITY AND STERILITY Copyright
More informationHormonal Control of Human Reproduction
Hormonal Control of Human Reproduction Bởi: OpenStaxCollege The human male and female reproductive cycles are controlled by the interaction of hormones from the hypothalamus and anterior pituitary with
More informationIn vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17,20-desmolase deficiency
FERTILITY AND STERILITY Vol. 55, No.5, May 1991 Copyright If) 1991 The American Fertility Society Printed on acid-free paper in U.S.A. In vitro fertilization as a diagnostic and therapeutic tool in a patient
More informationFirst you must understand what is needed for becoming pregnant?
What is infertility? Infertility means difficulty in becoming pregnant without using contraception. First you must understand what is needed for becoming pregnant? Ovum from the woman to combine with a
More informationREPRODUCCIÓN. La idea fija. Copyright 2004 Pearson Education, Inc., publishing as Benjamin Cummings
REPRODUCCIÓN La idea fija How male and female reproductive systems differentiate The reproductive organs and how they work How gametes are produced and fertilized Pregnancy, stages of development, birth
More informationHuman Anatomy and Physiology - Problem Drill 16: The Endocrine System
Human Anatomy and Physiology - Problem Drill 16: The Endocrine System Question No. 1 of 10 The endocrine system is made up of a number of organs and glands. Which one of the following is not an organ or
More informationMilder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization
Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization Revelli et al. Reproductive Biology and Endocrinology 2011, 9:25 Presenter: R2 孫怡虹 Background
More informationUniversal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D.
Universal Embryo Cryopreservation: Frozen versus Fresh Transfer Zaher Merhi, M.D. Disclosure: None Fewer complications with IVF 1.5% children in US are born through ART 1.1 million children since 2006
More informationChapter 14 Reproduction Review Assignment
Date: Mark: _/45 Chapter 14 Reproduction Review Assignment Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Use the diagram above to answer the next question.
More informationReproductive Endocrinology. Isabel Hwang Department of Physiology Faculty of Medicine University of Hong Kong Hong Kong May2007
Reproductive Endocrinology Isabel Hwang Department of Physiology Faculty of Medicine University of Hong Kong Hong Kong May2007 isabelss@hkucc.hku.hk A 3-hormone chain of command controls reproduction with
More informationThe intra-follicular molecular biology mandating advancement of egg retrieval in some women
The intra-follicular molecular biology mandating advancement of egg retrieval in some women David H. Barad, USA Director of Assisted Reproductive Technology, The Center for Human Reproduction New York
More informationTHE MENSTRUAL CYCLE INA S. IRABON, MD, FPOGS, FPSRM, FPSGE OBSTETRICS AND GYNECOLOGY REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY
THE MENSTRUAL CYCLE INA S. IRABON, MD, FPOGS, FPSRM, FPSGE OBSTETRICS AND GYNECOLOGY REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY REFERENCE Comprehensive Gynecology 7 th edition, 2017 (Lobo RA, Gershenson
More informationLeptin concentrations in the follicular phase of spontaneous cycles and cycles superovulated with follicle stimulating hormone
Human Reproduction vol.13 no.5 pp.1152 1156, 1998 Leptin concentrations in the follicular phase of spontaneous cycles and cycles superovulated with follicle stimulating hormone I.E.Messinis 1,4, S.Milingos
More information1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH.
1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH. 2. This causes the anterior pituitary to secrete small quantities of FSH and LH. 3. At this time, the follicles in the
More information% Oocyte Donation Pregnancyes (days 3)
Ovulation induction in oocyte donors Roma- September 2007 Dr. José Remohí Dr. Carmen Rubio Dr. Amparo Mercader Dr. Pilar Alama Dr. Marco Melo Evolution of oocyte donation cycles 1500 1500 1000 58% 661
More informationENDOCRINE CHARACTERISTICS OF ART CYCLES
ENDOCRINE CHARACTERISTICS OF ART CYCLES DOÇ. DR. SEBİHA ÖZDEMİR ÖZKAN KOCAELI UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, IVF UNIT 30.04.2014, ANTALYA INTRODUCTION The endocrine
More informationInvestigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle?
Investigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle? Introduction: The menstrual cycle (changes within the uterus) is an approximately 28-day cycle that
More informationPrognosticating ovarian reserve by the new ovarian response prediction index
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Tak A et al. Int J Reprod Contracept Obstet Gynecol. 2018 Mar;7(3):1196-1200 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20180917
More informationConcentrations of Luteinizing Hormone and Ovulatory Responses in Dairy Cows Before Timed Artificial Insemination
Concentrations of Luteinizing Hormone and Ovulatory Responses in Dairy Cows Before Timed Artificial Insemination S. L. Pulley, D. H. Keisler, S. L. Hill, and J. S. Stevenson Summary The objective of this
More informationSerum Estradiol Level as a Predictor of Ovarian Response and Pregnancy Outcome During Controlled Ovarian Hyperstimulation in Women from Gaza Strip
J MEDICINE 2013; 14 : 52-56 Serum Estradiol Level as a Predictor of Ovarian Response and Pregnancy Outcome During Controlled Ovarian Hyperstimulation in Women from Gaza Strip MAGED M. YASSIN, 1 MOHAMMED
More informationInfluence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser
Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte
More informationDaily blood hormone levels related to the luteinizing hormone surge in anovulatory cycles
FRTILITY AND STRILITY Copyright 1983 The American Fertility Society Printed in U.8A. Daily blood hormone levels related to the luteinizing hormone surge in anovulatory cycles Chung H. Wu, M.D. * F. Susan
More informationInfertility Clinical Guideline
Infertility Clinical Guideline Ovarian Stimulation Guideline Purpose: To provide sufficient background regarding various ovarian stimulation protocols for In Vitro Fertilization cycles. Goal: To assist
More informationA controlled study of gonadotropin-releasing hormone agonist (buserelin acetate*) for folliculogenesis in routine in vitro fertilization patients
FERTILITY AND STERILITY Copyright" 1991 The American Fertility Society Vol. 56, No. 3, September 1991 Printed on acid-free paper in U.S.A. A controlled study of gonadotropin-releasing hormone agonist (buserelin
More informationReproductive. Estradiol Analyte Information
Reproductive Estradiol Analyte Information - 1 - Estradiol Introduction Estradiol (E2 or 17β-estradiol) is the major estrogen in humans. Although it is often called the "female" hormone, it is also present
More informationProduction of steroids from human cumulus cells treated with different concentrations of gonadotropins during culture in vitro
FERTILITY AND STERILITY VOL. 71, NO. 1, JANUARY 1999 Copyright 1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Production of steroids
More informationIN VITRO FERTILIZATION OF RABBIT EGGS IN OVIDUCT SECRETIONS FROM DIFFERENT DAYS BEFORE AND AFTER OVULATION*
FERTILITY AND STERILITY Copyright~ 1975 The American Fertility Society Vol. 26, No.7, July 1975 Printed in U.SA. IN VITRO FERTILIZATION OF RABBIT EGGS IN OVIDUCT SECRETIONS FROM DIFFERENT DAYS BEFORE AND
More informationModule 3. Infertility: Protocols and Patient Management
Module 3 Infertility: Protocols and Patient Management Ann Scalia, BSN, RN, CNOR Manager Clinical Education Specialists Mary Vietzke, BSN, RN Senior Clinical Educational Specialist Walgreens Faculty Ann
More informationApproach to ovulation induction and superovulation in women with a history of infertility. Anatte E. Karmon, MD
Approach to ovulation induction and superovulation in women with a history of infertility Anatte E. Karmon, MD Disclosures- Anatte Karmon, MD No financial relationships to disclose 2 Objectives At the
More informationIN VITRO FERTILIZATION
FERTILITY AND STERILITY VOL. 72, NO. 5, NOVEMBER 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION
More informationAchieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center
Achieving Pregnancy: Obesity and Infertility Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Disclosures Speakers Bureau EMD Serono Board of Directors Nurse
More informationMULTIPLE CHOICE: match the term(s) or description with the appropriate letter of the structure.
Chapter 27 Exam Due NLT Thursday, July 31, 2015 Name MULTIPLE CHOICE: match the term(s) or description with the appropriate letter of the structure. Figure 27.1 Using Figure 27.1, match the following:
More information